Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 218Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Atozet

02 15Lipitor

PharmaCompass

01

Brand Name : Lipitor

Atorvastatin Calcium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 100

2019 Revenue in Millions : 121

Growth (%) : -17

blank

02

Brand Name : Lipitor

Atorvastatin Calcium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 1,973

2018 Revenue in Millions : 2,062

Growth (%) : -4

blank

03

Brand Name : Atozet

Atorvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Atozet

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 453

2019 Revenue in Millions : 391

Growth (%) : 16

blank

04

Brand Name : Lipitor

Atorvastatin Calcium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 19

2020 Revenue in Millions : 99

Growth (%) : -80

blank

05

Brand Name : Atozet

Atorvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Atozet

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 458

2020 Revenue in Millions : 453

Growth (%) : 1

blank

06

Brand Name : Atozet

Atorvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Atozet

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 457

2021 Revenue in Millions : 458

Growth (%) : 0

blank

07

Brand Name : Lipitor

Atorvastatin Calcium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin Calcium

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 1,635

2021 Revenue in Millions : 1,663

Growth (%) : -2

blank

08

Brand Name : Lipitor

Atorvastatin Calcium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin Calcium

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 1,559

2022 Revenue in Millions : 1,635

Growth (%) : -5

blank

09

Brand Name : Atozet

Atorvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Atozet

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 519

2022 Revenue in Millions : 457

Growth (%) : 14

blank

10

Brand Name : Lipitor

Atorvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Lipitor

arrow
2024 ACI Convention
Not Confirmed

Atorvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 144

2017 Revenue in Millions : 185

Growth (%) : -22%

blank